VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 18 filers reported holding VERONA PHARMA PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $0 | – | 59 | +1.7% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 58 | -50.4% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 117 | -73.5% | 0.00% | – |
| Q4 2019 | $2,000 | +100.0% | 442 | +18.2% | 0.00% | – |
| Q3 2019 | $1,000 | -98.1% | 374 | -96.4% | 0.00% | – |
| Q2 2019 | $52,000 | -30.7% | 10,274 | -12.0% | 0.00% | – |
| Q1 2019 | $75,000 | +36.4% | 11,674 | +89.1% | 0.00% | – |
| Q4 2018 | $55,000 | -65.6% | 6,174 | -51.9% | 0.00% | – |
| Q3 2018 | $160,000 | -9.1% | 12,834 | -0.8% | 0.00% | – |
| Q2 2018 | $176,000 | +417.6% | 12,934 | +660.4% | 0.00% | – |
| Q1 2018 | $34,000 | +385.7% | 1,701 | +183.5% | 0.00% | – |
| Q4 2017 | $7,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,249,918 | $69,273,663 | 7.59% |
| Aisling Capital Management LP | 1,115,352 | $18,180,238 | 7.49% |
| NEA Management Company, LLC | 5,108,563 | $91,031,474 | 7.03% |
| Octagon Capital Advisors LP | 2,369,000 | $38,614,700 | 5.93% |
| Knoll Capital Management, LLC | 200,000 | $3,260,000 | 3.38% |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $49,133,889 | 3.26% |
| Perceptive Advisors | 4,007,197 | $65,317,311 | 2.18% |
| RA Capital Management | 6,317,990 | $102,983,237 | 2.03% |
| Deep Track Capital, LP | 3,187,415 | $51,954,865 | 2.00% |
| Carlyle Group Inc. | 2,457,500 | $40,008,100 | 1.74% |